Verici Dx (LON:VRCI) Shares Up 4.4% – Still a Buy?

Verici Dx plc (LON:VRCI) shares traded up 4.4% on Thursday . The company traded as high as GBX 2.48 ($0.03) and last traded at GBX 2.48 ($0.03). 215,225 shares traded hands during mid-day trading, a decline of 36% from the average session volume of 333,685 shares. The stock had previously closed at GBX 2.38 ($0.03).

Verici Dx Price Performance

The company has a debt-to-equity ratio of 4.65, a quick ratio of 8.49 and a current ratio of 4.54. The stock has a market cap of £6.01 million, a PE ratio of -124.00 and a beta of 1.59. The stock has a 50 day moving average of GBX 3.09 and a two-hundred day moving average of GBX 5.44.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.